Category Specific RSS

News

Clinical trial reveals promising outcomes for children with paediatric autoimmune neuropsychiatric disorders

PANDAS and PANS are debilitating conditions characterised by distressing symptoms, ranging from rage to signs of obsessive compulsive disorder.

3 years ago

IPO Watch: Nido Education eyes ASX debut with vision for 100 centres

Australia's childcare industry is thriving, with revenue expected to reach $17.2 billion by 2028-29, according to market researcher IBISWorld, driven…

3 years ago

Happy Tummies gets more shelf space across Walmarts after Nutritional Growth Solutions reports new agreement

American retail giant Walmart has increased its commitment to the global nutrition company Nutritional Growth Solutions Ltd (ASX: NGS) by…

3 years ago

RemSense wins contract from Woodside Energy for virtual reality tech

Growing its influence across the resources industry, RemSense Technologies (ASX: REM) has won a new contract from Woodside Energy for…

3 years ago

BluGlass wins spot in US Department of Defence’s CLAWS Hub to produce semiconductor photonic devices

For over two years, China has dominated the global semiconductor chip supply, producing about 80% of it, with the US…

3 years ago

September 2023 Market Wrap and the ASX stocks that moved

US markets: US markets were lower, with the Dow Jones down -3.5% and S&P500 down -4.9%, as evidence of a resilient…

3 years ago

Roots Sustainable receives purchase order from Silal Food and Tech for its root zone cooling tech

Come 2025, the Agriculture Tech, or AgTech, market is set to be valued at $35.8 billion, more than double 2021’s…

3 years ago

Adacel secures new $93m air traffic management contract from the US’ Federal Aviation Administration

An ever-dynamic sector eager for constant enhancement, the air traffic control software industry is continually adapting to support the growing…

3 years ago

No false alarms: International Monitoring Group acquires 3,100 Securely customers for about $842k

Security systems company Intelligent Monitoring Group (ASX: IMB) has struck a deal to acquire a new security business through its…

3 years ago

Pharmaxis accelerates clinical drug developments with additional resources via sale of mannitol business to Arna Pharma

With a burgeoning pipeline of drugs deeply advanced, clinical stage biopharmaceuticals company Pharmaxis (ASX: PXS) has streamlined its business with…

3 years ago